Digitalis Ventures
VC Fund
New York, United States
Digitalis Ventures is a VC fund in New York focused on Biotechnology and Health Care. Digitalis is a venture capital firm that that invests in solutions to complex problems in human and animal health. Digitalis partners with entrepreneurs, inventors, and scientists across all stages of venture investing, and our investments span the full continuum of the healthcare ecosystem. It was founded in 2016 and is Headquartered in New York, New York with regional offices in Boston, Los Angeles, and San Francisco.
- Total investments:
- 120
- Last investment:
- Lead investor:
- 16%
- Fund size:
- $300M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Digitalis Ventures invests in
Stages Digitalis Ventures invests in
Countries Digitalis Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Seed
- $1.5M–$15M
- Series A
- $7.5M–$66M
- Series B
- $13M–$150M
Investment Focus
Industry
- Biotechnology 34 (28%)
- Health Care 26 (22%)
- Medical 18 (15%)
- Therapeutics 16 (13%)
- Pet 11 (9%)
Stage
- Series A 35 (29%)
- Seed 29 (24%)
- Series B 24 (20%)
- Series C 6 (5%)
- Venture - Series Unknown 4 (3%)
Country
- United States 61 (51%)
- United Kingdom 5 (4%)
- China 2 (2%)
- Canada 2 (2%)
- Australia 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Amit Bansal
Partner
|
Partner | Total investments: 4 | Find email | |
Cindy Cole
Partner
|
Partner | Total investments: 13 | Find email | |
Dac Nguye
Technical Partner
|
Technical Partner | Total investments: 0 | Find email | |
Drew Taylor
Partner
|
Partner | Total investments: 5 | Find email | |
Geoffrey W. Smith
founder and managing partner
|
founder and managing partner | Total investments: 20 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry libraryevolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology. | $150M / Series B / Oct 07, 2026 | ||
| Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologiessystematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.Enveda, launched in 2019, is based in San Francisco, California. | $311M / Series E / Sep 23, 2026 | ||
| Sparkle is a national wellness-focused dog grooming franchise and pioneer of Quick Service Pet Care (QSPC), a modern approach to routine pet care that combines membership-based services, technology-enabled operations, and a premium salon experience. The company provides recurring grooming and wellness services designed to keep dogs clean, healthy,and happy while helping franchise partners build scalable pet care businesses across the country. | $6M / Seed / Sep 09, 2026 | ||
| Buddy Bites focuses on providing convenient and healthy dog food, delivered directly to customers' doors. | $4.2M / Series A / Aug 20, 2026 | ||
| Omni is a plant-based pet food company from the UK, that is developing healthy, sustainable food for dogs. | $14.6M / Series A / Jun 22, 2026 | ||
| Neion Bio uses advances in stem cell biology and genetic engineering to completely reimagine the biopharmaceutical production process. | $23M / Series A / Jun 11, 2026 | ||
| Rejuvenate Bio is a biotechnology company that develops novel gene therapies for dogs. The company's therapy provides a solution for the mitral valve disease to stop the progression of heart failure in dogs, thus providing pets with extended overall health and maximal lifespan. It was founded in 2017 and is based in San Diego, CA. | $6M / Venture - Series Unknown / Jun 08, 2026 | ||
| Travv is a startup focused on veterinary diagnostics powered by AI. It offers cloud-based services connecting veterinarians worldwide with expert diagnosticians for streamlined workflows in areas like radiology, pathology, and cardiology. | $1.6M / Seed / May 06, 2026 | ||
| Stride Funding (AlmaPact Inc.) is a mission-driven company focused on enabling debt-free lives for students, by supplementing student loans with flexible income sharing agreements. Unlike student loans that lock students into a single rigid payment, Stride’s payments rise and fall with a student’s income so that payments are always affordable. Thecompany has been recognized as a visionary leader by FinTech analysts for its efforts on income protection and career support. Stride was created by students, for students, aiming to change student lives for the better. The company has been recognized by Harvard and MIT as a top new venture. Stride has received venture investments from GSV Accelerate, Slow Ventures, Sinai Ventures and Pear VC; and its strategic investors include Strada Education. Its advisors include serial entrepreneurs, Doug Levin and Tina Sharkey. Fund your Future, Find your Stride! | $20M / Series B / Mar 26, 2026 | ||
| Varda is a space manufacturing startup that focuses on creating products in space for terrestrial applications. They aim to manufacture things in space that benefit from low gravity. The company intends to create an infrastructure that harvests source materials for new products in-space via asteroid mining.The company was founded in 2020 byDelian Asparouhov and Trae Stephens. | Series D / Feb 17, 2026 | ||
| See all 120 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Digitalis Ventures invest in?
Digitalis Ventures invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Seed stage. Most of the 120 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Digitalis Ventures invest in?
Digitalis Ventures typically joins rounds of $1.5M–$15M at Seed, $7.5M–$66M at Series A and $13M–$150M at Series B. These are whole funding-round sizes, not Digitalis Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Digitalis Ventures took part in.
How do I contact Digitalis Ventures?
Public channels for Digitalis Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Digitalis Ventures?
The team at Digitalis Ventures includes Amit Bansal (Partner), Cindy Cole (Partner) and Dac Nguye (Technical Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
